159 related articles for article (PubMed ID: 31578317)
1. Clinical remission following ascorbate treatment in a case of acute myeloid leukemia with mutations in TET2 and WT1.
Das AB; Kakadia PM; Wojcik D; Pemberton L; Browett PJ; Bohlander SK; Vissers MCM
Blood Cancer J; 2019 Oct; 9(10):82. PubMed ID: 31578317
[No Abstract] [Full Text] [Related]
2. WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation.
Wang Y; Xiao M; Chen X; Chen L; Xu Y; Lv L; Wang P; Yang H; Ma S; Lin H; Jiao B; Ren R; Ye D; Guan KL; Xiong Y
Mol Cell; 2015 Feb; 57(4):662-673. PubMed ID: 25601757
[TBL] [Abstract][Full Text] [Related]
3.
Pasca S; Jurj A; Tomuleasa C; Zdrenghea M
Medicina (Kaunas); 2020 Nov; 56(12):. PubMed ID: 33255417
[No Abstract] [Full Text] [Related]
4. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia.
Rampal R; Alkalin A; Madzo J; Vasanthakumar A; Pronier E; Patel J; Li Y; Ahn J; Abdel-Wahab O; Shih A; Lu C; Ward PS; Tsai JJ; Hricik T; Tosello V; Tallman JE; Zhao X; Daniels D; Dai Q; Ciminio L; Aifantis I; He C; Fuks F; Tallman MS; Ferrando A; Nimer S; Paietta E; Thompson CB; Licht JD; Mason CE; Godley LA; Melnick A; Figueroa ME; Levine RL
Cell Rep; 2014 Dec; 9(5):1841-1855. PubMed ID: 25482556
[TBL] [Abstract][Full Text] [Related]
5. TET2 mutations in secondary acute myeloid leukemias: a French retrospective study.
Kosmider O; Delabesse E; de Mas VM; Cornillet-Lefebvre P; Blanchet O; Delmer A; Recher C; Raynaud S; Bouscary D; Viguié F; Lacombe C; Bernard OA; Ifrah N; Dreyfus F; Fontenay M;
Haematologica; 2011 Jul; 96(7):1059-63. PubMed ID: 21508122
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis.
Wang R; Gao X; Yu L
BMC Cancer; 2019 Apr; 19(1):389. PubMed ID: 31023266
[TBL] [Abstract][Full Text] [Related]
7. A new path to leukemia with WIT.
Sardina JL; Graf T
Mol Cell; 2015 Feb; 57(4):573-574. PubMed ID: 25699704
[TBL] [Abstract][Full Text] [Related]
8. Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.
Cimmino L; Dolgalev I; Wang Y; Yoshimi A; Martin GH; Wang J; Ng V; Xia B; Witkowski MT; Mitchell-Flack M; Grillo I; Bakogianni S; Ndiaye-Lobry D; Martín MT; Guillamot M; Banh RS; Xu M; Figueroa ME; Dickins RA; Abdel-Wahab O; Park CY; Tsirigos A; Neel BG; Aifantis I
Cell; 2017 Sep; 170(6):1079-1095.e20. PubMed ID: 28823558
[TBL] [Abstract][Full Text] [Related]
9. Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia.
Wang J; He N; Wang R; Tian T; Han F; Zhong C; Zhang C; Hua M; Ji C; Ma D
Sci Rep; 2020 Feb; 10(1):2706. PubMed ID: 32066746
[TBL] [Abstract][Full Text] [Related]
10. Mutations in TET2 and DNMT3A genes are associated with changes in global and gene-specific methylation in acute myeloid leukemia.
Ponciano-Gómez A; Martínez-Tovar A; Vela-Ojeda J; Olarte-Carrillo I; Centeno-Cruz F; Garrido E
Tumour Biol; 2017 Oct; 39(10):1010428317732181. PubMed ID: 28992762
[TBL] [Abstract][Full Text] [Related]
11. TET2 mutations in childhood leukemia.
Langemeijer SM; Jansen JH; Hooijer J; van Hoogen P; Stevens-Linders E; Massop M; Waanders E; van Reijmersdal SV; Stevens-Kroef MJ; Zwaan CM; van den Heuvel-Eibrink MM; Sonneveld E; Hoogerbrugge PM; van Kessel AG; Kuiper RP
Leukemia; 2011 Jan; 25(1):189-92. PubMed ID: 21042320
[No Abstract] [Full Text] [Related]
12. Monitoring of WT1 and its target gene IRF8 expression in acute myeloid leukemia and their significance.
Zhang Q; Zhang Q; Li Q; Liu B; Wang Y; Lin D; Zhou C; Li W; Tang K; Tian Z; Wang M; Wang J; Mi Y
Int J Lab Hematol; 2015 Aug; 37(4):e67-71. PubMed ID: 25387409
[No Abstract] [Full Text] [Related]
13. TET2 mutations in cytogenetically normal acute myeloid leukemia: clinical implications and evolutionary patterns.
Damm F; Markus B; Thol F; Morgan M; Göhring G; Schlegelberger B; Krauter J; Heuser M; Bernard OA; Ganser A
Genes Chromosomes Cancer; 2014 Oct; 53(10):824-32. PubMed ID: 24898826
[TBL] [Abstract][Full Text] [Related]
14. Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.
Nibourel O; Kosmider O; Cheok M; Boissel N; Renneville A; Philippe N; Dombret H; Dreyfus F; Quesnel B; Geffroy S; Quentin S; Roche-Lestienne C; Cayuela JM; Roumier C; Fenaux P; Vainchenker W; Bernard OA; Soulier J; Fontenay M; Preudhomme C
Blood; 2010 Aug; 116(7):1132-5. PubMed ID: 20489055
[TBL] [Abstract][Full Text] [Related]
15. Adverse prognostic effect of homozygous TET2 mutation on the relapse risk of acute myeloid leukemia in patients of normal karyotype.
Ahn JS; Kim HJ; Kim YK; Jung SH; Yang DH; Lee JJ; Lee IK; Kim NY; Minden MD; Jung CW; Jang JH; Kim HJ; Moon JH; Sohn SK; Won JH; Kim SH; Kim N; Yoshida K; Ogawa S; Kim DD
Haematologica; 2015 Sep; 100(9):e351-3. PubMed ID: 26045292
[No Abstract] [Full Text] [Related]
16. Hypoxia-sensitive epigenetic regulation of an antisense-oriented lncRNA controls WT1 expression in myeloid leukemia cells.
McCarty G; Loeb DM
PLoS One; 2015; 10(3):e0119837. PubMed ID: 25794157
[TBL] [Abstract][Full Text] [Related]
17. [Mutations in TET2 in myeloid cancers].
Bernard OA; Delhommeau F; Fontenay M; Vainchenker W
Med Sci (Paris); 2009 Oct; 25(10):785-8. PubMed ID: 19849974
[No Abstract] [Full Text] [Related]
18. A meta-analysis of TET2 mutations shows a distinct distribution pattern in de novo acute myeloid leukemia and chronic myelomonocytic leukemia.
Euba B; Vizmanos JL; García-Granero M; Aranaz P; Hurtado C; Migueliz I; Novo FJ; García-Delgado M
Leuk Lymphoma; 2012 Jun; 53(6):1230-3. PubMed ID: 22080757
[No Abstract] [Full Text] [Related]
19. Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.
Couronné L; Lippert E; Andrieux J; Kosmider O; Radford-Weiss I; Penther D; Dastugue N; Mugneret F; Lafage M; Gachard N; Nadal N; Bernard OA; Nguyen-Khac F
Leukemia; 2010 Jan; 24(1):201-3. PubMed ID: 19710701
[No Abstract] [Full Text] [Related]
20. Novel FNDC3B and MECOM fusion and WT1 L378fs* 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia.
Wang HY; McMahon C; Ali SM; Young LE; Yekezare S; Ross JS; Ball ED
Br J Haematol; 2016 Mar; 172(6):987-90. PubMed ID: 26147192
[No Abstract] [Full Text] [Related]
[Next] [New Search]
